FI960042A0 - Pharmaceuticals for difficult-to-soluble active substances - Google Patents

Pharmaceuticals for difficult-to-soluble active substances

Info

Publication number
FI960042A0
FI960042A0 FI960042A FI960042A FI960042A0 FI 960042 A0 FI960042 A0 FI 960042A0 FI 960042 A FI960042 A FI 960042A FI 960042 A FI960042 A FI 960042A FI 960042 A0 FI960042 A0 FI 960042A0
Authority
FI
Finland
Prior art keywords
active agent
component
pharmaceuticals
difficult
active substances
Prior art date
Application number
FI960042A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI960042A (en
FI116714B (en
Inventor
Ulrich Posanski
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6492300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI960042(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of FI960042A0 publication Critical patent/FI960042A0/en
Publication of FI960042A publication Critical patent/FI960042A/en
Application granted granted Critical
Publication of FI116714B publication Critical patent/FI116714B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Abstract

Pharmaceutical prepn. comprises () a pharmaceutically active agent which is sparingly soluble in water; and (b) a carrier compsn. comprising (i) at least one polyglycerine fatty acid ester and/or at least one sorbitan fatty acid ester, (ii) at least 1 conventional pharmaceutical oil contg. a triglyceride as lipophilic component and (iii) at least 1 nonionic surfactant with a HLB value of at least 10. The active agent is pref. a cyclosporin, rapamycin, tacrolimus, deoxyspergualine, nifedipine, nimodipine, etoposide, ibuprofen or alpha-lipoic acid. The active agent has a solubility, in distilled water, of less than 500mg/1000ml. The active agent concn. is 1-30 wt.%, based on the carrier compsn. The carrier compsn. comprises 10-50 wt.% component (i), 5-40 wt% component (ii) and 10-50 wt % component (iii).
FI960042A 1993-07-08 1996-01-04 The method produces pharmaceutical preparations for sparingly soluble active substances FI116714B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4322826 1993-07-08
DE4322826A DE4322826A1 (en) 1993-07-08 1993-07-08 Pharmaceutical preparation
PCT/EP1994/002238 WO1995001785A1 (en) 1993-07-08 1994-07-08 Pharmaceutical compositions for hardly soluble active substances
EP9402238 1994-07-08

Publications (3)

Publication Number Publication Date
FI960042A0 true FI960042A0 (en) 1996-01-04
FI960042A FI960042A (en) 1996-01-04
FI116714B FI116714B (en) 2006-02-15

Family

ID=6492300

Family Applications (2)

Application Number Title Priority Date Filing Date
FI960032A FI116197B (en) 1993-07-08 1996-01-03 Process for the preparation of pharmaceutical compositions for poorly soluble active substances
FI960042A FI116714B (en) 1993-07-08 1996-01-04 The method produces pharmaceutical preparations for sparingly soluble active substances

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI960032A FI116197B (en) 1993-07-08 1996-01-03 Process for the preparation of pharmaceutical compositions for poorly soluble active substances

Country Status (24)

Country Link
EP (3) EP1092429B1 (en)
JP (4) JPH08512303A (en)
KR (2) KR100359044B1 (en)
CN (2) CN1313154C (en)
AT (3) ATE201985T1 (en)
AU (2) AU689486B2 (en)
BR (1) BR9407002A (en)
CA (2) CA2164100A1 (en)
CY (2) CY2308B1 (en)
CZ (1) CZ291401B6 (en)
DE (6) DE4322826A1 (en)
DK (3) DK1092429T3 (en)
ES (3) ES2124420T3 (en)
FI (2) FI116197B (en)
GR (1) GR3036571T3 (en)
HU (2) HU228127B1 (en)
NO (2) NO306763B1 (en)
NZ (2) NZ269808A (en)
PL (1) PL179717B1 (en)
PT (2) PT1092429E (en)
RU (1) RU2140291C1 (en)
SI (1) SI1092429T1 (en)
SK (1) SK280615B6 (en)
WO (2) WO1995001786A1 (en)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH686761A5 (en) 1993-05-27 1996-06-28 Sandoz Ag Pharmaceutical formulations.
DE4322826A1 (en) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmaceutical preparation
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
US6413536B1 (en) * 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US6696413B2 (en) * 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
BE1009856A5 (en) 1995-07-14 1997-10-07 Sandoz Sa Pharmaceutical composition in the form of a solid release including macrolide and a vehicle.
GB2317562B (en) * 1995-07-20 1999-08-18 Danbiosyst Uk Lipid vehicle drug delivery composition containing vitamin E
GB9514878D0 (en) * 1995-07-20 1995-09-20 Danbiosyst Uk Vitamin E as a solubilizer for drugs contained in lipid vehicles
US5597582A (en) * 1995-09-12 1997-01-28 Sanofi Oral gel capsule formulation of 1,2,4-benzotriazine oxides
DE19549852B4 (en) * 1995-11-29 2009-06-04 Novartis Ag Cyclosporin containing preparations
CZ288631B6 (en) * 1996-01-18 2001-08-15 Galena, A. S. Therapeutic preparations containing cyclosporin
CZ288739B6 (en) * 1996-08-01 2001-08-15 Galena, A. S. Cyclosporin containing medicinal preparations
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
WO1998046268A1 (en) * 1997-04-11 1998-10-22 Fujisawa Pharmaceutical Co., Ltd. Medicinal composition
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
ID25908A (en) * 1998-03-06 2000-11-09 Novartis Ag EMULSION PRACTONCENTRATES CONTAINING CYCLOSPORINE OR MACROLIDES
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
AU2878801A (en) * 1999-10-01 2001-05-10 Natco Pharma Limited An improved pharmaceutical composition and a process for its preparation
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US20040039036A1 (en) * 2000-11-24 2004-02-26 Yoshimi Hashimoto Water-soluble liquid internal medicine
DE10161077A1 (en) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions for needleless injection
EP1455810B1 (en) 2001-12-14 2007-06-13 Jagotec Ag Pharmaceutical formulation comprising cyclosporin and use thereof
KR100533458B1 (en) 2002-07-20 2005-12-07 대화제약 주식회사 Composition for solubilization of paclitaxel and preparation method thereof
GB2391473B (en) * 2002-08-02 2004-07-07 Satishchandra Punambhai Patel Pharmaceutical compositions
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1603560A1 (en) 2003-02-06 2005-12-14 Cipla Ltd. Topical immunotherapy and compositions for use therein
JPWO2004073692A1 (en) * 2003-02-18 2006-06-01 山下　伸二 Hard capsule of poorly water-soluble drug
PT2279729T (en) * 2003-07-17 2016-09-22 Banner Life Sciences Llc Controlled release preparations
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
GB0425255D0 (en) * 2004-11-16 2004-12-15 Novartis Ag Pharmaceutical composition
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
CN101252837A (en) * 2005-07-28 2008-08-27 瑞莱恩特医药品有限公司 Treatment with dihydropyridine calcium channel blockers and Omega-3 fatty acids and a combination product thereof
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
PT2117521E (en) 2006-11-03 2012-09-10 Durect Corp Transdermal delivery systems comprising bupivacaine
EP1952807A1 (en) * 2007-01-24 2008-08-06 LEK Pharmaceuticals D.D. Sirolimus formulation
ITMI20070720A1 (en) * 2007-04-06 2008-10-07 Monteresearch Srl ORAL COMPOSITIONS CONTAINING TACROLIMUS IN AMORPHOUS FORM
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
EA023244B1 (en) * 2009-04-10 2016-05-31 Хаян Ки Method for preventing cell senescence
WO2011046853A1 (en) 2009-10-12 2011-04-21 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
JP5970224B2 (en) 2011-07-11 2016-08-17 株式会社日本自動車部品総合研究所 Spark plug for internal combustion engine
KR20140071913A (en) * 2012-12-04 2014-06-12 삼성정밀화학 주식회사 Food composition and soft capsule including the same
RU2015147696A (en) * 2013-04-09 2017-05-12 Бостон Байомедикал, Инк. METHODS FOR TREATING A MALIGNANT TUMOR
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
PT3215127T (en) * 2014-11-07 2021-02-10 Sublimity Therapeutics Ltd Compositions comprising cyclosporin
US20170072058A1 (en) 2014-11-21 2017-03-16 Solipharma Llc Pharmaceutical composition containing tacrolimus and preparation methods thereof
HRP20211488T1 (en) 2016-04-20 2022-02-18 Veroscience Llc Composition and method for treating metabolic disorders
WO2018098501A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
CA3079522A1 (en) * 2017-10-18 2019-04-25 Veroscience Llc Improved bromocriptine formulations
EA202092131A1 (en) * 2018-03-14 2020-11-27 Кэнди Терапьютикс Лимитед NEW PHARMACEUTICAL PREPARATION CONTAINING DUAL ANTAGONISTS OF THE NK-1 / NK-3 RECEPTOR
CN108853044B (en) * 2018-07-06 2020-11-06 郑州明泽医药科技有限公司 Nifedipine sustained release tablet and preparation method thereof
KR20220140711A (en) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 Reduced Impurity Sustained Release Drug Delivery Systems and Related Methods
KR102524312B1 (en) * 2020-12-15 2023-04-21 윤관식 Water-soluble emulsion composition comprising ecdysteroid
KR102583074B1 (en) * 2021-01-25 2023-09-25 윤관식 Water-soluble emulsion composition comprising natural polyphenolic compound
WO2022131656A1 (en) * 2020-12-15 2022-06-23 윤관식 Alkaloid-containing, water-soluble emulsified composition
CN113041236B (en) * 2021-03-23 2023-03-10 广州新济药业科技有限公司 Flurbiprofen cataplasm and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132518A (en) * 1965-02-18 1968-11-06 Richardson Merrell Inc Medicinal composition
IT1090703B (en) * 1976-12-03 1985-06-26 Scherer Ltd R P IMPROVEMENT IN USEFUL COMPOSITIONS SUCH AS DRUG VEHICLES
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
JPH0832638B2 (en) * 1989-05-25 1996-03-29 カイロン コーポレイション Adjuvant formulation comprising submicron oil droplet emulsion
JPH0525037A (en) * 1991-07-01 1993-02-02 Upjohn Co:The Oral administrative enzyme sensitive enteric coating
DE4322826A1 (en) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmaceutical preparation

Also Published As

Publication number Publication date
PL179717B1 (en) 2000-10-31
CN1121853C (en) 2003-09-24
HUT73427A (en) 1996-07-29
PT710103E (en) 2001-11-30
ES2159564T3 (en) 2001-10-16
DE59410365D1 (en) 2004-04-22
ES2218046T3 (en) 2004-11-16
RU2140291C1 (en) 1999-10-27
AU689486B2 (en) 1998-04-02
PT1092429E (en) 2004-08-31
CZ4596A3 (en) 1996-04-17
EP0710103A1 (en) 1996-05-08
DE59407239D1 (en) 1998-12-10
NO960069D0 (en) 1996-01-05
NO960062D0 (en) 1996-01-05
CA2164100A1 (en) 1995-01-19
DE59409787D1 (en) 2001-07-19
SI1092429T1 (en) 2004-08-31
NZ269808A (en) 1996-07-26
SK1996A3 (en) 1997-04-09
GR3036571T3 (en) 2001-12-31
BR9407002A (en) 1996-09-03
ATE201985T1 (en) 2001-06-15
EP0710104A1 (en) 1996-05-08
EP0710103B1 (en) 2001-06-13
CY2308B1 (en) 2003-11-14
CN1128495A (en) 1996-08-07
PL312255A1 (en) 1996-04-01
DK0710104T3 (en) 1999-07-19
CA2166204A1 (en) 1995-01-19
CN1496743A (en) 2004-05-19
WO1995001786A1 (en) 1995-01-19
ATE261720T1 (en) 2004-04-15
HUT73661A (en) 1996-09-30
NO306763B1 (en) 1999-12-20
CA2166204C (en) 2009-04-14
SK280615B6 (en) 2000-05-16
EP1092429B1 (en) 2004-03-17
DE4322826A1 (en) 1995-01-12
FI960032A (en) 1996-02-09
FI116197B (en) 2005-10-14
HU228127B1 (en) 2012-12-28
CY2604B2 (en) 2010-04-28
KR100359044B1 (en) 2003-02-05
NO960062L (en) 1996-01-05
DE4494850D2 (en) 1996-08-22
ES2124420T3 (en) 1999-02-01
KR100386533B1 (en) 2003-08-21
AU7345794A (en) 1995-02-06
AU7385094A (en) 1995-02-06
JP2009138008A (en) 2009-06-25
EP1092429A1 (en) 2001-04-18
NZ269552A (en) 1996-07-26
NO306929B1 (en) 2000-01-17
FI960042A (en) 1996-01-04
CN1313154C (en) 2007-05-02
CZ291401B6 (en) 2003-03-12
JPH08512301A (en) 1996-12-24
HU9503868D0 (en) 1996-02-28
DE4494851D2 (en) 1996-12-19
WO1995001785A1 (en) 1995-01-19
JP2011153150A (en) 2011-08-11
FI960032A0 (en) 1996-01-03
HU223073B1 (en) 2004-03-01
DK1092429T3 (en) 2004-07-19
JPH08512303A (en) 1996-12-24
NO960069L (en) 1996-01-05
ATE172876T1 (en) 1998-11-15
DK0710103T3 (en) 2001-09-24
EP0710104B1 (en) 1998-11-04
HU9503965D0 (en) 1996-03-28
FI116714B (en) 2006-02-15

Similar Documents

Publication Publication Date Title
FI960042A (en) Pharmaceuticals for difficult-to-soluble active substances
BR9509496A (en) Pharmaceutical compositions
EA200200415A1 (en) COMPOSITION OF PHARMACEUTICAL MEDIA

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FG Patent granted

Ref document number: 116714

Country of ref document: FI

MA Patent expired